JAZZ Annual ROE
12.16%
+18.52%+291.19%
31 December 2023
Summary:
As of January 22, 2025, JAZZ annual return on equity is 12.16%, with the most recent change of +18.52% (+291.19%) on December 31, 2023. During the last 3 years, it has risen by +5.11% (+72.48%). JAZZ annual ROE is now -93.87% below its all-time high of 198.47%, reached on December 31, 2008.JAZZ ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Quarterly ROE
12.28%
+1.44%+13.28%
30 September 2024
Summary:
As of January 22, 2025, JAZZ quarterly return on equity is 12.28%, with the most recent change of +1.44% (+13.28%) on September 30, 2024. Over the past year, it has increased by +9.81% (+397.17%). JAZZ quarterly ROE is now -97.43% below its all-time high of 478.08%, reached on December 31, 2008.JAZZ Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +291.2% | +397.2% |
| 3 y3 years | +72.5% | +397.2% |
| 5 y5 years | -25.6% | +397.2% |
JAZZ ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +240.6% | at high | +206.1% |
| 5 y | 5-year | -31.8% | +240.6% | -31.3% | +206.1% |
| alltime | all time | -93.9% | +104.8% | -97.4% | +100.6% |
Jazz Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 12.28%(+13.3%) |
| June 2024 | - | 10.84%(+16.6%) |
| Mar 2024 | - | 9.30%(-23.0%) |
| Dec 2023 | 12.16%(-291.2%) | 12.08%(+389.1%) |
| Sept 2023 | - | 2.47%(-190.8%) |
| June 2023 | - | -2.72%(-44.4%) |
| Mar 2023 | - | -4.89%(-27.6%) |
| Dec 2022 | -6.36%(-26.5%) | -6.75%(+1150.0%) |
| Sept 2022 | - | -0.54%(-60.9%) |
| June 2022 | - | -1.38%(-88.1%) |
| Mar 2022 | - | -11.57%(+36.8%) |
| Dec 2021 | -8.65%(-222.7%) | -8.46%(+98.6%) |
| Sept 2021 | - | -4.26%(-483.8%) |
| June 2021 | - | 1.11%(-92.8%) |
| Mar 2021 | - | 15.44%(+108.4%) |
| Dec 2020 | 7.05%(-60.5%) | 7.41%(+28.2%) |
| Sept 2020 | - | 5.78%(+31.1%) |
| June 2020 | - | 4.41%(-53.8%) |
| Mar 2020 | - | 9.54%(-46.6%) |
| Dec 2019 | 17.84%(+9.1%) | 17.88%(-14.5%) |
| Sept 2019 | - | 20.92%(-8.3%) |
| June 2019 | - | 22.82%(+33.0%) |
| Mar 2019 | - | 17.16%(+8.7%) |
| Dec 2018 | 16.35%(-23.1%) | 15.79%(-15.7%) |
| Sept 2018 | - | 18.74%(+12.6%) |
| June 2018 | - | 16.64%(-9.6%) |
| Mar 2018 | - | 18.40%(-15.2%) |
| Dec 2017 | 21.26%(-6.9%) | 21.69%(+19.4%) |
| Sept 2017 | - | 18.17%(-13.7%) |
| June 2017 | - | 21.05%(-8.3%) |
| Mar 2017 | - | 22.95%(-1.8%) |
| Dec 2016 | 22.83%(+2.9%) | 23.37%(+5.3%) |
| Sept 2016 | - | 22.19%(-2.8%) |
| June 2016 | - | 22.82%(+2.6%) |
| Mar 2016 | - | 22.25%(-1.6%) |
| Dec 2015 | 22.19% | 22.62%(-3.2%) |
| Sept 2015 | - | 23.36%(+18.3%) |
| June 2015 | - | 19.74%(+16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | 16.89%(+279.6%) |
| Dec 2014 | 4.38%(-75.5%) | 4.45%(+78.0%) |
| Sept 2014 | - | 2.50%(-61.7%) |
| June 2014 | - | 6.53%(0.0%) |
| Mar 2014 | - | 6.53%(-63.8%) |
| Dec 2013 | 17.90%(-59.2%) | 18.03%(-44.3%) |
| Sept 2013 | - | 32.35%(+4.9%) |
| June 2013 | - | 30.85%(-3.0%) |
| Mar 2013 | - | 31.82%(-15.9%) |
| Dec 2012 | 43.92%(-60.8%) | 37.84%(+70.8%) |
| Sept 2012 | - | 22.15%(-27.3%) |
| June 2012 | - | 30.45%(-40.5%) |
| Mar 2012 | - | 51.20%(-56.9%) |
| Dec 2011 | 111.92%(+4.3%) | 118.73%(-32.7%) |
| Sept 2011 | - | 176.47%(-59.3%) |
| June 2011 | - | 433.64%(+102.2%) |
| Mar 2011 | - | 214.50%(-219.4%) |
| Dec 2010 | 107.29%(+1042.6%) | -179.61%(+577.5%) |
| Sept 2010 | - | -26.51%(-1788.5%) |
| June 2010 | - | 1.57%(-116.1%) |
| Mar 2010 | - | -9.73%(-219.7%) |
| Dec 2009 | 9.39%(-95.3%) | 8.13%(-89.6%) |
| Sept 2009 | - | 77.90%(-37.0%) |
| June 2009 | - | 123.70%(-46.8%) |
| Mar 2009 | - | 232.64%(-51.3%) |
| Dec 2008 | 198.47%(-178.6%) | 478.08%(-153.7%) |
| Sept 2008 | - | -889.71%(+172.5%) |
| June 2008 | - | -326.45%(+51.1%) |
| Mar 2008 | - | -216.07%(-39.2%) |
| Dec 2007 | -252.45%(-849.3%) | -355.46%(-82.8%) |
| Sept 2007 | - | -2067.86%(+134.3%) |
| June 2007 | - | -882.51%(-883.4%) |
| Mar 2007 | - | 112.65%(+234.4%) |
| Dec 2006 | 33.69%(-53.2%) | 33.69%(-41.7%) |
| Sept 2006 | - | 57.80%(-11.6%) |
| June 2006 | - | 65.37%(-10.4%) |
| Mar 2006 | - | 72.94%(+1.3%) |
| Dec 2005 | 72.01% | 72.01% |
FAQ
- What is Jazz Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual ROE year-on-year change?
- What is Jazz Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly ROE year-on-year change?
What is Jazz Pharmaceuticals annual return on equity?
The current annual ROE of JAZZ is 12.16%
What is the all time high annual ROE for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual return on equity is 198.47%
What is Jazz Pharmaceuticals annual ROE year-on-year change?
Over the past year, JAZZ annual return on equity has changed by +18.52% (+291.19%)
What is Jazz Pharmaceuticals quarterly return on equity?
The current quarterly ROE of JAZZ is 12.28%
What is the all time high quarterly ROE for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly return on equity is 478.08%
What is Jazz Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, JAZZ quarterly return on equity has changed by +9.81% (+397.17%)